Table 2.
Laboratory data & lung function parameters of patient #2
| Reference range, adults | Prior to PRRT | 3 weeks after PRRT | 10 weeks after1st PRRT | After 2x PRRT |
After 4x PRRT |
|
|---|---|---|---|---|---|---|
| Hemoglobulin (g/dL) | 12-16 | 12.1 | 12.2 | 11.8 | 12.0 | 12.1 |
| White-cell count (per mm3) | 4,500-11,000 | 3,100 | 2,900 | 3,500 | 2,800 | 3,100 |
| Absolute neutrophil count (ANC, per mm3) | 1,200-7,200 | 2,092 | n/a | n/a | 1,764 | 1,760 |
| Differential count (%) | ||||||
| Neutrophils | 41-70 | 67.5 | n/a | n/a | 63.0 | 60.8 |
| Platelet count (per mm3) | 150,000-450,000 | 145,000 | n/a | 209,000 | 207,000 | 186,000 |
| Creatinine( mg/dL) | 0.0-0.95 | 0.69 | 0.54 | 0.70 | 0.70 | 0.72 |
| Estimated glomerular filtration rate (mL/min 1.73 m2; CKD-EPI) | 105 | n/a | 105 | 104 | 101 | |
| Soluble interleukin-2 receptor (U/mL) | ≤900 | 1,504 | 1,570 | n/a | 1,233 | 1,164 |
| Neopterin (nM) | <10 | n/a | n/a | n/a | 17.9 | 11.9 |
| ACE (U/L) | 20-70 | >120 | 138 | n/a | 159 | 119.8 |
| Lung function | ||||||
| VC IN | 2.91 | 2.68 | 2.13 | 2.07 | 2.45 | |
| FVC | 2.85 | 2.49 | 2.08 | 2.14 | 2.15 | |
| FEV 1 | 2.44 | 1.88 | 1.52 | 1.53 | 1.52 | |
| FEV 1 % FVC | 75.33 | 73.03 | 71.22 | 70.94 | ||
| ERV (L) | 1.0 | 0.16 | n/a | 0.12 | 0.25 | |
| PEF (L/s) | 6.12 | 3.3 | 2.91 | 2.86 | 2.63 | |
| MEF 75 (L/s) | 5.50 | 2.73 | n/a | 2.22 | 2.23 | |
| MEF 50 (L/s) | 3.86 | 1.89 | 1.32 | 1.25 | 1.15 | |
| MEF 25 (L/s) | 1.62 | 0.49 | n/a | 0.34 | 0.23 | |
| VC (L) | 2.91 | 2.68 | 2.13 | 2.31 | 2.45 | |
| FRCpleth (L) | 2.54 | 1.88 | 1.42 | 2.15 | 1.92 | |
| RV (L) | 1.54 | 1.72 | n/a | 2.03 | 1.67 | |
| TLC (L) | 4.51 | 4.41 | 3.40 | 4.34 | 4.12 | |
| R tot (kPa·s/L) | 0.30 | 0.84 | n/a | 0.72 | 0.82 | |
| SR tot (kPa·s) | 0.96 | 1.85 | n/a | 1.85 | 1.85 | |
| R eff (kPa·s/L) | 0.30 | 0.60 | n/a | 0.58 | 0.53 |